US markets close mixed as tech stocks push back

RTHK - Nov 6, 2026

US technology stocks bounced back on Friday from their worst drubbing in more than a year, but the Nasdaq Composite Index posted a fourth consecutive weekly decline as investors sifted for clues about what comes next in the AI trade. Gains within technology were broadly shared, with the semiconductor index rallying and Nvidia, Advanced Micro Devices and Sandisk rebounding. The broad revival underscores investor faith in the AI buildout that has driven US stock indexes to dozens of record closes this year, despite a shakeout that began with a US long-term Treasury yield spike in August and the stock volatility of the past month. “We still think AI is the dominant theme in this bull market,” said Keith Lerner, chief investment officer at Trust Advisory Services in Atlanta. “We are still giving technology the benefit of the doubt.” The S&P 500 climbed 24.70 points, or 0.34 percent to end the session at 7,378.43. The Nasdaq gained 264.42 points, or 1.09 percent, to 24,579.42, while the Dow Jones Industrial Average declined 237.33 points, or 0.46 percent, to 51,285.73. Lerner said he views the selloff this week, which has taken the Nasdaq into correction territory denoting a 10 percent decline from its peak a month ago, as...

Read full article

MORE NEWS

article.head.headline
Nov 6, 2026
If You *Hate* Being Unprepared On A Trip, You Def Need One Of These 36 Items

If you like to plan for the plot twists before they happen, you've come to the right place. View Entire Post ›

article.head.headline
Nov 6, 2026
How Farmers’ Frustration With Trump’s Policies Helped Democrats

Anger over tariffs and higher costs because of the war in Iran led many Republican farmers and ranchers to vote blue — or stay home.

article.head.headline
Nov 6, 2026
38 Affordable But Useful Travel Products You’ll Be Oh So Smug You Bought In Advance

Travel just gets easier and breezier with this portable folding stool and Skims-like base layer you can get for under $10 each. View Entire Post ›

article.head.headline
Nov 6, 2026
They Spent Millions to Keep Their Dream Cruise Afloat. It Died Anyway.

Secrecy, debt and soaring fuel costs all contributed to the Odyssey’s downfall. Here’s an inside look at how the “endless cruise” unraveled.

article.head.headline
Nov 6, 2026
They Spent Millions to Keep Their Dream Cruise Afloat. It Died Anyway.

Secrecy, debt and soaring fuel costs all contributed to the Odyssey’s downfall. Here’s an inside look at how the “endless cruise” unraveled.

article.head.headline
Nov 6, 2026
All infants should be vaccinated against hep B, says Canadian vaccine advisory committee

The National Advisory Committee on Immunization now recommends that all Canadian infants receive vaccination against hepatitis B, a virus that infects the liver and has a high likelihood of becoming chronic in young children, especially infants under one year old.

article.head.headline
Nov 6, 2026
Why the US midterms sparked an AI stock selloff

Fears of more AI regulation appear to have sparked fear among investors, but concerns about the industry have been growing for some time.

article.head.headline
Nov 6, 2026
Tesla Is Ending Production of Its Cybertruck and Refocusing on the Cybercab

Production of the electric trucks will stop in the middle of 2027 to make room for increased production of its autonomous ride-share vehicle, Elon Musk said.

article.head.headline
Nov 6, 2026
Why smoky bacon crisps threaten to reignite rows over EU rules

A post-Brexit deal on food standards has raised questions over the future naming of the classic British snack.

article.head.headline
Nov 6, 2026
What Shaped Anthropic CEO Dario Amodei’s Thinking on A.I.

Some call him a doomer. Others see him as a responsible technologist. Here’s how Dario Amodei’s thinking on artificial intelligence was shaped.

article.head.headline
Nov 6, 2026
Food bank to close amid rising costs

A food bank in Goole annouces it will close in January as costs rise and donations drop.

article.head.headline
Nov 6, 2026
Moderna's mRNA flu and flu-COVID combo vaccines have been approved by Health Canada

Health Canada has authorized Moderna's mRNA vaccine for influenza, as well as its combination mRNA vaccine for flu and COVID-19.